quetiapine viatris 100 mg filmomh. tabl.
viatris gx bv-srl - quetiapinefumaraat 115,13 mg - eq. quetiapine 100 mg - filmomhulde tablet - 100 mg - quetiapinefumaraat 115.13 mg - quetiapine
quetiapine viatris 200 mg filmomh. tabl.
viatris gx bv-srl - quetiapinefumaraat 230,26 mg - eq. quetiapine 200 mg - filmomhulde tablet - 200 mg - quetiapinefumaraat 230.26 mg - quetiapine
quetiapine viatris 25 mg filmomh. tabl.
viatris gx bv-srl - quetiapinefumaraat 28,78 mg - eq. quetiapine 25 mg - filmomhulde tablet - 25 mg - quetiapinefumaraat 28.78 mg - quetiapine
quetiapine viatris 300 mg filmomh. tabl.
viatris gx bv-srl - quetiapinefumaraat 345,39 mg - eq. quetiapine 300 mg - filmomhulde tablet - 300 mg - quetiapinefumaraat 345.39 mg - quetiapine
quetiapine viatris 100 mg filmomh. tabl.
viatris gx bv-srl - quetiapinefumaraat 115,13 mg - eq. quetiapine 100 mg - filmomhulde tablet - quetiapine
quetiapine viatris 200 mg filmomh. tabl.
viatris gx bv-srl - quetiapinefumaraat 230,26 mg - eq. quetiapine 200 mg - filmomhulde tablet - quetiapine
quetiapine viatris 25 mg filmomh. tabl.
viatris gx bv-srl - quetiapinefumaraat 28,78 mg - eq. quetiapine 25 mg - filmomhulde tablet - quetiapine
quetiapine viatris 300 mg filmomh. tabl.
viatris gx bv-srl - quetiapinefumaraat 345,39 mg - eq. quetiapine 300 mg - filmomhulde tablet - quetiapine
rybrevant
janssen-cilag international n.v. - amivantamab - carcinoom, niet-kleincellige long - antineoplastische middelen - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
tsefalen 500 mg filmomh. tabl.
icf srl industria chemica fine - cefalexine 500 mg - filmomhulde tablet - 500 mg - celafexinemonohydraat - cefalexin - hond